{"id":"staphylococcus-and-neisseria-tablets","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The tablet formulation presents bacterial antigens from Staphylococcus and Neisseria species to the immune system, triggering both humoral and cellular immune responses. This approach aims to provide protective immunity against infections caused by these gram-positive and gram-negative bacteria respectively. The exact antigenic composition and delivery mechanism are not publicly detailed.","oneSentence":"This is a vaccine formulation containing antigens from Staphylococcus and Neisseria bacteria designed to stimulate immune responses against these pathogens.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:09:41.672Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of Staphylococcus infections"},{"name":"Prevention of Neisseria infections"}]},"trialDetails":[{"nctId":"NCT06895460","phase":"PHASE3","title":"A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-06-20","conditions":"Bronchial Asthma","enrollment":198},{"nctId":"NCT05407792","phase":"NA","title":"Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2022-06-06","conditions":"Bronchiectasis","enrollment":134},{"nctId":"NCT05975788","phase":"PHASE4","title":"Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":750},{"nctId":"NCT05543343","phase":"NA","title":"Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.","status":"UNKNOWN","sponsor":"Qu Yiqing","startDate":"2022-01-05","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":495}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["H37023540"],"phase":"marketed","status":"active","brandName":"Staphylococcus and Neisseria Tablets","genericName":"Staphylococcus and Neisseria Tablets","companyName":"Peking University Third Hospital","companyId":"peking-university-third-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a vaccine formulation containing antigens from Staphylococcus and Neisseria bacteria designed to stimulate immune responses against these pathogens. Used for Prevention of Staphylococcus infections, Prevention of Neisseria infections.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}